Outcomes of Stereotactic Body Radiotherapy for Metastatic Colorectal Cancer With Oligometastases, Oligoprogression, or Local Control of Dominant Tumors

AIM: To evaluate the clinical outcomes of metastatic colorectal cancer (mCRC) patients with oligometastases, oligoprogression, or local control of dominant tumors after stereotactic body radiotherapy (SBRT) and establish a nomogram model to predict the prognosis for these patients. METHODS AND MATER...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Xiaoqin, Zhao, Yulu, Zhu, Xixu, Shen, Zetian, Li, Aomei, Chen, Cheng, Chu, Xiaoyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878536/
https://www.ncbi.nlm.nih.gov/pubmed/33585211
http://dx.doi.org/10.3389/fonc.2020.595781

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878536/
https://www.ncbi.nlm.nih.gov/pubmed/33585211
http://dx.doi.org/10.3389/fonc.2020.595781

Ejemplares similares